packageLanadelumab

lanadelumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lanadelumab, a monoclonal antibody, is used to treat hereditary angioedema. It is authorised in the European Union and is an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q25326708 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lanadelumab
ATC codes:B06AC05
DrugBank:DB14597
Wikidata:Q25326708
molar mass:146000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown